Keywords: Seattle Genetics, Abbott Labs, ADC collaboration, Oncology targets

Seattle Genetics and Abbott expand ADC collaboration

Article | 24 October 2012

Print This

US biotech firm Seattle Genetics (Nasdaq: SGEN) says it has expanded its antibody-drug conjugate (ADC) collaboration with health care major ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in